Heterogeneity in the clastogenic response to X-rays in lymphocytes from ataxia-telangiectasia heterozygotes and controls
- PMID: 1610970
- DOI: 10.1007/BF00124257
Heterogeneity in the clastogenic response to X-rays in lymphocytes from ataxia-telangiectasia heterozygotes and controls
Abstract
A coded analysis of X-ray-induced chromatid aberrations in lymphocyte cultures from 45 control individuals and 19 ataxia-telangiectasia (A-T) heterozygotes was performed. The distribution of chromatid breaks induced in the late G2 portion of the cell cycle by 60 cGy of X-rays appeared bimodal in the study population. In six controls (13 percent) and in 12 of 19 (63 percent) A-T heterozygotes, the yields of X-ray-induced breaks observed were within the higher mode of the distribution. However, lymphocytes from A-T heterozygotes sensitive to the induction of chromatid breaks by 60 cGy did not contain increased numbers of aberrations following exposure to 20 cGy. The radio-resistant inhibition of DNA synthesis that occurs in A-T homozygotes was not observed in heterozygotes. Co-cultivation experiments showed an increased G2 delay in lymphocytes from an A-T heterozygote whose lymphocytes contained increased X-ray-induced chromatid breaks. The results show a significant association of A-T heterozygosity with G2 chromosomal sensitivity (P less than 0.001; Wilcoxon rank sum test). The measurement of X-ray-induced breaks, however, failed to identify 37 percent of A-T heterozygotes tested. The predicted prevalence of increased sensitivity to X-rays in controls is approximately three- to 30-fold greater than the estimated frequency of A-T heterozygotes in the general population. Therefore, although the increased sensitivity to X-ray-induced chromatid breaks appears to be associated with the A-T-gene, it is not a reliable indicator of A-T heterozygosity. Genetic or environmental factors other than the A-T gene also must be involved in the increased clastogenic response.
Similar articles
-
Detection of heterozygous carriers of the ataxia-telangiectasia (ATM) gene by G2 phase chromosomal radiosensitivity of peripheral blood lymphocytes.Hum Genet. 1997 Dec;101(3):312-6. doi: 10.1007/s004390050634. Hum Genet. 1997. PMID: 9439660
-
Comparative study of radiation-induced G2 phase delay and chromatid damage in families with ataxia-telangiectasia.Cancer Genet Cytogenet. 1994 Aug;76(1):43-6. doi: 10.1016/0165-4608(94)90069-8. Cancer Genet Cytogenet. 1994. PMID: 8076350
-
G2 chromosomal radiosensitivity in ataxia telangiectasia lymphocytes.Mutat Res. 1985 Oct;152(1):39-47. doi: 10.1016/0027-5107(85)90044-2. Mutat Res. 1985. PMID: 4047083
-
G2 chromosomal radiosensitivity of ataxia-telangiectasia heterozygotes.Cancer Genet Cytogenet. 1985 Jan 1;14(1-2):163-8. doi: 10.1016/0165-4608(85)90227-4. Cancer Genet Cytogenet. 1985. PMID: 3965121
-
Possible role of chromatin alteration in the radiosensitivity of ataxia-telangiectasia.Int J Radiat Biol. 1994 Dec;66(6 Suppl):S109-13. Int J Radiat Biol. 1994. PMID: 7836837 Review.
Cited by
-
Transcriptional Dynamics of DNA Damage Responsive Genes in Circulating Leukocytes during Radiotherapy.Cancers (Basel). 2022 May 26;14(11):2649. doi: 10.3390/cancers14112649. Cancers (Basel). 2022. PMID: 35681629 Free PMC article.
-
Individual Radiosensitivity Assessment of the Families of Ataxia-Telangiectasia Patients by G2-Checkpoint Abrogation.Sultan Qaboos Univ Med J. 2018 Nov;18(4):e440-e446. doi: 10.18295/squmj.2018.18.04.003. Epub 2019 Mar 28. Sultan Qaboos Univ Med J. 2018. PMID: 30988961 Free PMC article.
-
The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?Oncotarget. 2017 Jan 10;8(2):1957-1971. doi: 10.18632/oncotarget.12699. Oncotarget. 2017. PMID: 27779110 Free PMC article.
-
Assessment of targeted and non-targeted responses in cells deficient in ATM function following exposure to low and high dose X-rays.PLoS One. 2014 Mar 28;9(3):e93211. doi: 10.1371/journal.pone.0093211. eCollection 2014. PLoS One. 2014. PMID: 24681528 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical